Coverart for item
The Resource DNA repair in cancer therapy : molecular targets and clinical applications, edited by Mark R. Kelley, (electronic book)

DNA repair in cancer therapy : molecular targets and clinical applications, edited by Mark R. Kelley, (electronic book)

Label
DNA repair in cancer therapy : molecular targets and clinical applications
Title
DNA repair in cancer therapy
Title remainder
molecular targets and clinical applications
Statement of responsibility
edited by Mark R. Kelley
Contributor
Subject
Language
eng
Member of
Cataloging source
VVL
Dewey number
616.99/4061
Illustrations
illustrations
Index
index present
LC call number
RC271.A684
LC item number
D64 2012eb
Literary form
non fiction
Nature of contents
  • dictionaries
  • bibliography
http://library.link/vocab/relatedWorkOrContributorName
Kelley, Mark R
http://library.link/vocab/subjectName
  • DNA repair
  • Cancer
  • Antimutagens
  • DNA Repair
  • Neoplasms
  • Neoplasms
Label
DNA repair in cancer therapy : molecular targets and clinical applications, edited by Mark R. Kelley, (electronic book)
Instantiates
Publication
Note
This book is available on the World Wide Web. Editions may vary. Access is restricted to computers located within Mount Sinai or to those users eligible for remote access services
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction and Overview of DNA Repair Targets: From Bench to Clinic -- MGMT: A Critical DNA Repair Gene Target for Chemotherapy Resistance and for Stem Cell Protection -- Blockade of Base Excision Repair: Inhibition of Small Lesions Results in Big Consequences to Cancer Cells -- The Role of PARP in DNA Repair and its Therapeutic Exploitation -- Chemotherapeutic Intervention by Inhibiting DNA Polymerases -- Targeting the Nucleotide Excision Repair Pathway for Therapeutic Applications -- Targeting Homologous Recombination Repair in Cancer -- DNA Double-Strand Break Repair by Non-homologous End Joining and Its Clinical Relevance -- Defective DNA Mismatch Repair-dependent c-Abl-p--3-GADD45a Expression Confers Cancer Chemoresistance -- Checkpoint Kinase and Wee1 Inhibitors as Anticancer Therapeutics -- Apurinic/Apyrimindinic Endonuclease in Redox Regulation and Oxidative Stress: Implications for Regulation of DNA Repair and Therapeutic Development -- Personalized Cancer Medicine: DNA Repair Alterations Are Promising Predictive Biomarkers in Cancer -- The Role of DNA Damage and Repair in Neurotoxicity Caused by Cancer Therapies -- Future Directions with DNA Repair Inhibitors: A Roadmap for Disruptive Approaches to Cancer Therapy
Control code
SCIDI747982895
Dimensions
unknown
Edition
1st ed.
Extent
1 online resource (xi, 362 pages)
Form of item
online
Isbn
9780123849991
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote
Label
DNA repair in cancer therapy : molecular targets and clinical applications, edited by Mark R. Kelley, (electronic book)
Publication
Note
This book is available on the World Wide Web. Editions may vary. Access is restricted to computers located within Mount Sinai or to those users eligible for remote access services
Bibliography note
Includes bibliographical references and index
Carrier category
online resource
Carrier category code
  • cr
Carrier MARC source
rdacarrier
Color
mixed
Content category
text
Content type code
  • txt
Content type MARC source
rdacontent
Contents
Introduction and Overview of DNA Repair Targets: From Bench to Clinic -- MGMT: A Critical DNA Repair Gene Target for Chemotherapy Resistance and for Stem Cell Protection -- Blockade of Base Excision Repair: Inhibition of Small Lesions Results in Big Consequences to Cancer Cells -- The Role of PARP in DNA Repair and its Therapeutic Exploitation -- Chemotherapeutic Intervention by Inhibiting DNA Polymerases -- Targeting the Nucleotide Excision Repair Pathway for Therapeutic Applications -- Targeting Homologous Recombination Repair in Cancer -- DNA Double-Strand Break Repair by Non-homologous End Joining and Its Clinical Relevance -- Defective DNA Mismatch Repair-dependent c-Abl-p--3-GADD45a Expression Confers Cancer Chemoresistance -- Checkpoint Kinase and Wee1 Inhibitors as Anticancer Therapeutics -- Apurinic/Apyrimindinic Endonuclease in Redox Regulation and Oxidative Stress: Implications for Regulation of DNA Repair and Therapeutic Development -- Personalized Cancer Medicine: DNA Repair Alterations Are Promising Predictive Biomarkers in Cancer -- The Role of DNA Damage and Repair in Neurotoxicity Caused by Cancer Therapies -- Future Directions with DNA Repair Inhibitors: A Roadmap for Disruptive Approaches to Cancer Therapy
Control code
SCIDI747982895
Dimensions
unknown
Edition
1st ed.
Extent
1 online resource (xi, 362 pages)
Form of item
online
Isbn
9780123849991
Media category
computer
Media MARC source
rdamedia
Media type code
  • c
Other physical details
illustrations
Specific material designation
remote

Library Locations

Processing Feedback ...